| Name | Title | Contact Details |
|---|
LuxCath is the leader in using fluorescence and optics to directly view lesions during cardiac ablation procedures. The company`s breakthrough technology offers the potential for dramatic evolution in the way ablation procedures are performed by assessing tissue contact and enabling direct lesion progression monitoring. LuxCath`s patented solution aims to ensure the quality of catheter lesions at the moment they are made. LuxCath enables constant optical tissue contact assessment and provides valuable lesion formation and progression information during each ablation.
Aria CV, Inc: Improving the lives of patients suffering from the disease of pulmonary hypertension.
Sebacia is a clinical-stage` private medical device company dedicated to creating breakthrough topical therapies for the treatment of dermatological conditions affecting millions of people. Sebacia’s goal is to provide a better alternative to the daily use of topical and systemic drugs currently available for the treatment of acne. Sebacia’s microparticles technology was invented and licensed from Rice University` and the dermatology applications were further developed with researchers from and the Wellman Center of Photomedicine at Massachusetts General Hospital. Sebacia is located in Duluth` Georgia
ANATOMICA AB is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Vittamed is an early stage medical technology company developing innovative ultrasound-based non-invasive neuro diagnostic and monitoring technologies including the measurement of absolute value of intracranial pressure, real time cerebral blood flow autoregulation and intracranial volumetric wave monitoring.